Article info
Basic and translational research
Extended report
Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations
- Correspondence to Dr John H Stone, Rheumatology Clinic/Yawkey 2, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA; jhstone{at}partners.org
Citation
Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations
Publication history
- Received January 12, 2014
- Revised April 7, 2014
- Accepted April 16, 2014
- First published May 9, 2014.
Online issue publication
October 31, 2019
Article Versions
- Previous version (31 October 2019).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Files in this Data Supplement:
- Data supplement 1 - Online supplement
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions